“A targeted chemotherapy drug approved for treatment of breast cancer showed clinical benefit in patients with treatment-resistant uterine cancer.
Original story
Continue reading at Yale News - Health & Medicine
news.yale.edu
Summary generated from the RSS feed of Yale News - Health & Medicine. All article rights belong to the original publisher. Click through to read the full piece on news.yale.edu.
